Drug intelligence / Profile preview

Theravex Tissue Care Plus

Development stage: Preclinical
Lead developer: Biointelligent Technology System
Administration: Topical

Overview

Theravex Tissue Care Plus is a non-pharmaceutical, nutrient-based topical therapy developed by Biointelligent Technology Systems. Utilizing Bone Bioactive Liquid (BBL) technology, the product is designed to accelerate tissue healing and regeneration across various clinical contexts, including dental surgery, diabetic wound care, and cosmetic recovery. Its mechanism of action involves the attraction of progenitor stem cells to the site of injury, optimization of wound hydration, enhancement of intercellular communication, and regulation of inflammatory factors. It is primarily used to support osseointegration in dental implants and to promote soft tissue repair.

Brand names: Theravex Tissue Care Plus
Other names: Bone Bioactive LiquidBBL

Beyond the preview

Go deeper on Theravex Tissue Care Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Theravex Tissue Care Plus.

Explore the full profile